These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 37537279)
21. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
31. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818 [TBL] [Abstract][Full Text] [Related]
32. The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study. Harvey SB; Wadsworth M; Wessely S; Hotopf M Psychol Med; 2008 Jul; 38(7):933-40. PubMed ID: 17976252 [TBL] [Abstract][Full Text] [Related]
33. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus? Hatziagelaki E; Adamaki M; Tsilioni I; Dimitriadis G; Theoharides TC J Pharmacol Exp Ther; 2018 Oct; 367(1):155-167. PubMed ID: 30076265 [TBL] [Abstract][Full Text] [Related]
34. Assessing severity of illness and outcomes of treatment in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a systematic review of patient-reported outcome measures (PROMs). Haywood KL; Collin SM; Crawley E Child Care Health Dev; 2014 Nov; 40(6):806-24. PubMed ID: 24661148 [TBL] [Abstract][Full Text] [Related]